Head-to-head · WeighScore
Kongo vs Mint Med
By GLP-1 ScorecardUpdated
Score comparison
Kongo has the higher recorded score — 83.8/100 to 78.7/100.
Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded injection plans with written support; confirm the charge, supplied quantity and renewal terms.
Before you choose
Mint Med does not publish a semaglutide price, so its Mint Med review sets out what it does disclose, while the Kongo review explains the conditions attached to Kongo's figure. The semaglutide cost page compares published rates across the field. Ask Mint Med for a written total before treating either one as the cheaper choice.
If neither one fits, Kongo vs NextMeds and Luma Health Co vs Mint Med compare each of them with another graded program, and the list of alternatives to Kongo ranks the programs closest to Kongo on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Eden review covers one graded close to these two, at 81.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Kongo | Mint Med |
|---|---|---|
| WeighScore | 83.8/100 | 78.7/100 |
| Grade | B | C+ |
| Site position | #19 | #44 |
| Semaglutide | $109 one-month plan or $285 every three months advertised; confirm selected charge and supply. | Product and catalog prices conflict; confirm selected plan charge and supply. |
| Tirzepatide | $209 one-month or $387 three-month plan advertised; confirm selected charge and supply. | Catalog title and starting price differ; confirm selected charge and supply. |
| Coverage | All 50 advertised; confirm treatment-specific state availability. | Homepage says 35 states but lists 36; confirm treatment-specific eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Regular one-month and prepaid totals published
- Medication, care, supplies and shipping advertised included
- Portal cancellation and clinical messaging
What to consider
- Refund and refill cutoffs need confirmation
- Operator and footer entities need clarification
- Assigned clinician and pharmacy not established
- Telephone support marked coming soon
FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.
Strengths
- Published monthly and prepaid plan choices
- Portal access for treatment questions
What to consider
- Advertised prices conflict
- Processed orders generally final
- Prepaid cancellation can require repricing
- Assigned pharmacy and clinician need confirmation
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.